The Pradaxa Resource Center warns that Pradaxa carries a higher risk of death and internal bleeding than other blood thinners. Unfortunately, this news is too late for many patients who took Pradaxa and suffered serious bleeds or death. On December 7, 2011, the FDA began investigating the safety of Pradaxa after receiging higher than expected reports of injury or death. The manufacturer of Pradaxa reports thta it has received more than 260 death reports from the use of Pradaxa.
The early results of a recent study sponsored by Alere, Inc. were presented on May 4, 2012 at the 2012 Thrombosis and Hemotasis Summit of North America. The study followed 2,200 patients who switched from warfarin to Pradaxa. The early results indicate that only .88% of patients experienced complications while on warfarin. Shockingly, 11.5% of these same patients experiencede complications while taking Pradaxa. These complications included bleeding, heart attack, stroke, and death.
Once Pradaxa causes internal bleeding, it is difficult for doctors to stop the bleeding. With most blood thinners, a reversal agent is readily available to doctors in emergencies. By contrast, as a March 6, 2012 report in the Journal of Neurology stated, no such agent exists for Pradaxa.
Many users of Pradaxa have suffered strokes, death and serious internal bleeding as a result of taking the drug. If you or a loved one have suffered an injury after taking Pradaxa, please contact our experienced Pradaxa and product liability attorneys for a free consultation at (888) 606-5297.
Patient Advocacy Group Warns Patients that Pradaxa has a Higher Rate of Death and Internal Bleeding than Other Blood Thinners